Sarcopenia may Influence the Prognosis in Advanced Thyroid Cancer Patients Treated With Molecular Targeted Therapy

Conclusion: Sarcopenia could be a prognostic factor in patients with advanced thyroid cancer receiving molecular targeted therapy.

Source: In Vivo - January 5, 2021 Category: Research Authors: NISHIYAMA, A., STAUB, Y., SUGA, Y., FUJITA, M., TANIMOTO, A., OHTSUBO, K., YANO, S. Tags: Clinical Studies Source Type: research